Isomorphic Labs
AI-driven drug discovery platform building predictive and generative models for pharmaceutical research and development
Highlights
- Hiring32 open roles
- Remote-friendly32 of 32 open roles remote or hybrid
About Isomorphic Labs
Isomorphic Labs builds AI models for drug discovery, described on its website as building on and beyond the AlphaFold system. Its stated aim is to design novel molecules, anticipate how drugs will perform, and develop medicines.
The company works on drug design and development, with research teams in London and Cambridge, Massachusetts. Its website describes its team as drug discovery experts and machine learning specialists, and it lists partnerships as a section of the site.
The company's website lists offices in London and Cambridge, MA, with open roles across research, clinical, engineering, security and finance functions. Its leadership team includes Sir Demis Hassabis as founder and CEO and Max Jaderberg as President.
Product: AI predictive and generative models for drug design and discovery
Jobs at Isomorphic Labs (32)
Isomorphic Labs is hiring for 32 roles based in London and Cambridge.
Senior Legal Counsel, Corporate Transactions, Cambridge, MA
Remote-friendlyResearch Lead / Senior Scientist (DMPK), London
Remote-friendlyResearch Lead (Formulation Sciences), London
Remote-friendlyResearch Leader (Toxicology), London
Remote-friendlyHead of External Drug Discovery Operations, London
Remote-friendlyTechnical Program Manager (DDMR), Cambridge, MA
Remote-friendlySenior Finance Business Partner (Clinical), Cambridge, MA
Remote-friendly
Companies hiring like Isomorphic Labs
Leadership
- Demis Hassabis · Founder and CEOSource: company website
- Beverley Mallon · Chief People & Experience OfficerSource: company website
More biotech & pharma companies
Istesso
Develops oral mitochondrial Complex I modulator medicines to restore tissue repair; lead candidate leramistat is in Phase 2New on EvolcItf Pharma
Rare-disease pharmaceutical company developing treatments for Duchenne muscular dystrophy in the UK and IrelandYoung companyNew on EvolcJanssen-Cilag
Medicines and medical technologies for patients, healthcare professionals and healthcare systemsNew on EvolcSalary transparentKiniksa Pharmaceuticals International, PLC
Biopharmaceutical company developing immune-modulating therapies, focused on cardiovascular diseases such as recurrent pericarditisYoung companyNew on EvolcKinomica
Phosphoproteomic diagnostic platform KScan for cancer treatment-response prediction, for clinicians and drug developersNew on EvolcRemote-friendlyKirkstall
Organ-on-a-chip flow cell culture systems for studying drug toxicity and disease in academic and pharma labsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- AWS
- Cloudflare
- Cookiebot
- Google Analytics 4
- Google Cloud
- Greenhouse
- Webflow